Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
Possession or use of investigational drugs outside an authorized clinical trial may be illegal in your jurisdiction
This material is supplied strictly for research use only and is not intended for diagnosis, treatment, prevention, or consumption
Research has demonstrated that AOD-9604 increases beta-3 receptor expression in adipose tissue, potentially improving mobilization from resistant areas
US$ 25.62
US$ 27.03
US$ 23.24
US$ 28.93
US$ 26.94
US$ 21.99
US$ 28.10
US$ 25.67
US$ 26.52
US$ 28.72
US$ 24.80
US$ 23.65
US$ 29.30
US$ 23.20
US$ 20.83
